DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,903 | +15.0% | 23,794 | +6.4% | 0.46% | +10.1% |
| Q2 2023 | $5,133 | -8.9% | 22,354 | 0.0% | 0.42% | -9.5% |
| Q1 2023 | $5,634 | -5.0% | 22,354 | 0.0% | 0.46% | -9.8% |
| Q4 2022 | $5,933 | -99.9% | 22,354 | +3.1% | 0.51% | -1.4% |
| Q3 2022 | $5,601,000 | +1.9% | 21,684 | 0.0% | 0.52% | +5.7% |
| Q2 2022 | $5,497,000 | -7.3% | 21,684 | +7.2% | 0.49% | +7.9% |
| Q1 2022 | $5,932,000 | +1.8% | 20,224 | +14.2% | 0.45% | +4.8% |
| Q4 2021 | $5,828,000 | -6.2% | 17,714 | -13.2% | 0.43% | -15.1% |
| Q3 2021 | $6,215,000 | +13.5% | 20,414 | 0.0% | 0.51% | +13.1% |
| Q2 2021 | $5,478,000 | +19.2% | 20,414 | 0.0% | 0.45% | +7.9% |
| Q1 2021 | $4,595,000 | +27.8% | 20,414 | +26.1% | 0.42% | +19.1% |
| Q4 2020 | $3,595,000 | -22.5% | 16,184 | -24.9% | 0.35% | -31.2% |
| Q3 2020 | $4,641,000 | -8.7% | 21,554 | -29.4% | 0.51% | -14.9% |
| Q2 2020 | $5,086,000 | +20.4% | 30,524 | 0.0% | 0.60% | +0.7% |
| Q1 2020 | $4,225,000 | -3.3% | 30,524 | +7.3% | 0.60% | -8.7% |
| Q4 2019 | $4,367,000 | -13.2% | 28,454 | -18.3% | 0.65% | -20.0% |
| Q3 2019 | $5,033,000 | +1.1% | 34,845 | 0.0% | 0.82% | -1.0% |
| Q2 2019 | $4,980,000 | +29.1% | 34,845 | +19.3% | 0.82% | +22.1% |
| Q1 2019 | $3,856,000 | +45.6% | 29,205 | +13.7% | 0.67% | +9.8% |
| Q4 2018 | $2,648,000 | -5.1% | 25,681 | 0.0% | 0.61% | +10.8% |
| Q3 2018 | $2,790,000 | +10.1% | 25,681 | 0.0% | 0.55% | +3.4% |
| Q2 2018 | $2,534,000 | +0.8% | 25,681 | 0.0% | 0.54% | -3.6% |
| Q1 2018 | $2,514,000 | +5.5% | 25,681 | 0.0% | 0.56% | +6.3% |
| Q4 2017 | $2,384,000 | -8.9% | 25,681 | -15.8% | 0.52% | -12.5% |
| Q3 2017 | $2,617,000 | +1.7% | 30,504 | 0.0% | 0.60% | -5.4% |
| Q2 2017 | $2,574,000 | -1.3% | 30,504 | 0.0% | 0.63% | -7.7% |
| Q1 2017 | $2,609,000 | +9.9% | 30,504 | 0.0% | 0.68% | +0.4% |
| Q4 2016 | $2,374,000 | – | 30,504 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |